Drugs News and Research

RSS

Findings open up improved treatment possibilities for children suffering from leukaemia

A research team led by Nanyang Technological University (NTU) scientists have made a key finding which is expected to open up improved treatment possibilities for children suffering from leukaemia.

14 Aug 2014

World Health Organization approves use of experimental Ebola treatment

The drugs have not yet been through FDA testing, but WHO says they can be used for "compassionate use" to help in the African outbreak. However, manufacturers may not have many supplies available.

14 Aug 2014

Researchers discover new clue to understanding how TB medication attacks dormant TB bacteria

Researchers at the Johns Hopkins Bloomberg School of Public Health say they have discovered a new clue to understanding how the most important medication for tuberculosis (TB) works to attack dormant TB bacteria in order to shorten treatment.

13 Aug 2014

Researchers make significant step forward in understanding mechanisms that cause leukaemia

Scientists from Queen Mary University of London have discovered mutations in genes that lead to childhood leukaemia of the acute lymphoblastic type - the most common childhood cancer in the world.

13 Aug 2014

Novogen declares shareholder meeting results

Australia-US biotechnology company, Novogen Ltd., an oncology and degenerative diseases drug development company, today announced the results of its General Meeting of Shareholders, which was held on August 12 in Sydney, Australia.

13 Aug 2014

Phase 2 study: Rigel's R348 fails to meet endpoints in patients with dry eye disease

Rigel Pharmaceuticals, Inc. today announced that R348, its ophthalmic JAK/SYK inhibitor, did not meet the primary or secondary endpoints in a recently completed Phase 2 clinical study in patients with dry eye disease.

13 Aug 2014

First Edition: August 13, 2014

Today's headlines include reports that more than 300,000 people who obtained new insurance through the health law could lose it if they do not provide proof by Sept. 5 that their immigration or citizenship status makes them eligible for it.

13 Aug 2014

Only 52% of women receive low-cost treatment to prevent babies death

A major international study of more than 303 000 births in 29 low-income and middle-income countries has found that only half (52%) of women who are eligible to receive a simple, effective, low-cost treatment to prevent death and disability in their newborn babies are getting it.

13 Aug 2014

Federal program that provides billions in drug discounts faces number of critical issues

A federal program that provides billions in drug discounts to safety net hospitals and other health care providers is expanding under health care reform, but divergent views on the purpose and future scope of the program creates uncertainty for safety net providers and drug manufacturers, according to new report from the RAND Corporation.

13 Aug 2014

Identifying epigenetic markers in cancer cells could improve patient treatment

Scientists have known for decades that cancer can be caused by genetic mutations, but more recently they have discovered that chemical modifications of a gene can also contribute to cancer.

13 Aug 2014

Experts to debate healthy labor and delivery practices at Cedars-Sinai Birth Community Day

Doctors, nurses, midwives and doulas will debate healthy labor and delivery practices - including the use of the synthetic hormone Pitocin to hasten childbirth and vitamin K to speed blood clotting in newborns -- at the third annual Cedars-Sinai Birth Community Day, Aug. 14.

13 Aug 2014

Researchers gain rare insight into pregnancy-associated breast cancer

During pregnancy, certain hormones trigger specialized mammary stem cells to create milk-producing cells essential to lactation.

13 Aug 2014

Researchers develop new way of using electricity to open blood-brain-barrier

A team of researchers from the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences have developed a new way of using electricity to open the blood-brain-barrier (BBB).

13 Aug 2014

New approach to predict myeloma patients using calcium isotope analysis

A team of researchers from Arizona State University and Mayo Clinic is showing how a staple of Earth science research can be used in biomedical settings to predict the course of disease.

13 Aug 2014

Blood expression levels of genes targeted by stress hormones could be biomarker for developing PTSD

Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing Post-Traumatic Stress Disorder (PTSD), according to a study conducted in rats by researchers at the Icahn School of Medicine at Mount Sinai and published August 11 in Proceedings of the National Academy of Sciences (PNAS).

13 Aug 2014

Researchers find new ways to treat hormone receptor-positive breast cancer

A leading scientist based at Keele University in North Staffordshire has been awarded a grant of around £20,000 by research charity Breast Cancer Campaign to find new ways to treat hormone receptor-positive breast cancer, the most common type of the disease.

13 Aug 2014

Study: Brain tumors hijack the brain's existing blood supply during progression

Dangerous brain tumors hijack the brain's existing blood supply throughout their progression, by growing only within narrow potential spaces between and along the brain's thousands of small blood vessels, new research shows for the first time.

12 Aug 2014

Cochrane review finds little evidence to support use of sleep or wake drugs for shift workers

Shift workers are taking drugs to help them stay awake or get to sleep despite weak evidence for their benefit, according to a new Cochrane review.

12 Aug 2014

OncoSynergy's OS2966 receives FDA orphan drug designation for treatment of glioblastoma

OncoSynergy announced today that the FDA Office of Orphan Products Development has granted orphan drug designation for the investigational drug candidate OS2966, a neutralizing anti-CD29 monoclonal antibody, for the treatment of glioblastoma, the most common and deadliest primary adult brain tumor.

12 Aug 2014

Feist-Weiller, Caris Life Sciences partner to offer breakthrough technology to cancer patients

Doctors at the LSU Health Shreveport Feist-Weiller Cancer Center will now have access to innovative, precision-medicine technology that determines the unique biological characteristics of each individual patient's cancer tumor.

12 Aug 2014

Drugs News and Research

Findings open up improved treatment possibilities for children suffering from leukaemia

World Health Organization approves use of experimental Ebola treatment

Researchers discover new clue to understanding how TB medication attacks dormant TB bacteria

Researchers make significant step forward in understanding mechanisms that cause leukaemia

Novogen declares shareholder meeting results

Phase 2 study: Rigel's R348 fails to meet endpoints in patients with dry eye disease

First Edition: August 13, 2014

Only 52% of women receive low-cost treatment to prevent babies death

Federal program that provides billions in drug discounts faces number of critical issues

Identifying epigenetic markers in cancer cells could improve patient treatment

Experts to debate healthy labor and delivery practices at Cedars-Sinai Birth Community Day

Researchers gain rare insight into pregnancy-associated breast cancer

Researchers develop new way of using electricity to open blood-brain-barrier

New approach to predict myeloma patients using calcium isotope analysis

Blood expression levels of genes targeted by stress hormones could be biomarker for developing PTSD

Researchers find new ways to treat hormone receptor-positive breast cancer

Study: Brain tumors hijack the brain's existing blood supply during progression

Cochrane review finds little evidence to support use of sleep or wake drugs for shift workers

OncoSynergy's OS2966 receives FDA orphan drug designation for treatment of glioblastoma

Feist-Weiller, Caris Life Sciences partner to offer breakthrough technology to cancer patients

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News